MDMenghua Dai

Menghua Dai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Menghua Dai has a total of 123 co-authors. Here are the top co-authors by number of shared publications:

  • Yupei Zhao

    General Surgery Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

    16 shared publications
  • Quan Liao

    Department of General Surgery, Peking Union Medical College Hospital, Beijing 100730, China

    7 shared publications
  • Yatong Li

    7 shared publications
  • Taiping Zhang

    Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China

    6 shared publications
  • Qiang Xu

    Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    5 shared publications
  • Junchao Guo

    Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    4 shared publications

Latest Publications

  • Transabdominal ultrasound subclassification of pancreatic serous cystic neoplasms: correlation with MRI and characterization of subtype-specific features

    by Xiaoyi Yan, Yuming Shao, Yang Gui, Erjia Guo, Huijia Zhao, Bo Kong, Wanying Jia, Hua Liang, Menghua Dai, Weibin Wang, et al.

    Objectives To characterize the transabdominal ultrasound (US) features of pancreatic serous cystic neoplasm (SCN) morphological subtypes, evaluate US-MRI agreement, and explore reducing overtreatment. Materials and methods This retrospective study included 125 patients with pathologically confirmed pancreatic SCNs who underwent preoperative US. Lesions were morphologically classified into macrocystic, microcystic, mixed, and solid subtypes. US-MRI concordance (71 patients, 56.8%) was assessed using Cohen’s kappa. Demographics, grayscale features, and CEUS patterns (exploratory n = 14) were described. Results US demonstrated excellent agreement with MRI for SCN subtyping (κ = 0.817, 95% CI: 0.711–0.923). Macrocystic was most common (38.4%) and occurred in younger patients (42.0 ± 12.3 years, p < 0.001). Overall, exophytic growth (84.1%) was a hallmark feature. Mixed subtypes exhibited the highest lobulation rate (p < 0.001) and peripheral macrocysts, whereas solid subtypes were predominantly non-lobulated. US and MRI discrepancies arose when microcysts were too small to resolve on US, mimicking solid. On CEUS, microcystic SCNs showed honeycomb architecture, whereas solid SCNs demonstrated arterial iso- or slight hyper-enhancement followed by slow washout. Conclusion Conventional US provides reliable morphological subtyping of SCNs, comparable to MRI. Recognizing fine internal architectures, distinctive growth patterns (exophytic/lobulated), and the potential value of slow CEUS washout patterns may aid in the characterization of SCNs and provide supportive information for differential diagnosis. Given that most SCNs are benign and do not require routine intervention, improved non‑invasive characterization by US can help inform clinical decision‑making and potentially reduce surgical overtreatment.

  • Identifying a better-prognosis pancreatic cancer from its benign inflammatory mimic: a machine learning approach with contrast-enhanced ultrasound for early intervention

    by Hua Liang, Ruiyang Gao, Yang Gui, Xueqi Chen, Tianjiao Chen, Li Tan, Wanying Jia, Menghua Dai, Weibin Wang, Junchao Guo, et al.

    Purpose Hypervascular pancreatic ductal adenocarcinoma (PDAC) and mass-forming pancreatitis (MFP) represent a classic diagnostic mimicry on contrast-enhanced ultrasound, as both exhibit similar arterial-phase hyperenhancement, precluding reliable visual distinction. Crucially, the hypervascular PDAC subtype is associated with a more favorable prognosis, rendering its accurate identification from its benign inflammatory mimic (MFP) a clinically significant priority for early and appropriate intervention. This study aimed to develop and validate a small-sample–oriented machine learning framework leveraging quantitative time-intensity curve (TIC) features to achieve this precise differentiation. Materials and methods We retrospectively included 152 patients with pathologically confirmed lesions who underwent CEUS between September 2017 and April 2024 (85 hypervascular PDAC, 67 MFP). A temporally separated split was used: 122 patients (2017–2022) formed the training cohort and 30 patients (2023–2024) served as the internal test cohort. Paired TICs were generated from the lesion and adjacent normal pancreatic parenchyma, and 22 quantitative difference/ratio features describing enhancement amplitude, temporal kinetics and curve morphology were extracted. Based on independent-samples t-tests and clinical interpretability, five representative TIC features were selected to train six classical classifiers (logistic regression, support vector machine, k-nearest neighbors, random forest, naïve Bayes, and decision tree). Model performance was assessed by stratified 10-fold cross-validation on the training cohort and by testing on the temporally separated cohort. Results In nested cross-validation, all models achieved AUCs of approximately 0.89–0.92. On the test cohort, AUCs ranged from about 0.83 to 0.92, with logistic regression performing best (AUC 0.915). Overall, the six classifiers showed broadly comparable discrimination. Conclusion A machine-learning model built on a small set of physiologically interpretable CEUS-TIC features can provide stable and explainable quantitative support for differentiating hypervascular PDAC from MFP, even under limited-sample conditions.

  • Open Access

    Development and validation of a nomogram model based on ultrasound and contrast-enhanced ultrasound features for differentiating mass-forming pancreatitis and pancreatic ductal adenocarcinoma

    by Hua Liang, Yang Gui, Xueqi Chen, Tianjiao Chen, Jing Zhang, Li Tan, Wanying Jia, Menghua Dai, Weibin Wang, Junchao Guo, et al.

    Purpose To explore the value of ultrasound (US) and contrast-enhanced ultrasound (CEUS) in differentiating mass-forming Pancreatitis (MFP) and pancreatic ductal adenocarcinoma (PDAC). Methods This retrospective study analyzed clinical and imaging data from 281 patients who underwent pancreatic CEUS between January 2018 and December 2023. Patients were randomly divided into training (n = 196) and validation (n = 85) sets. Logistic regression analyses were conducted to identify independent predictive imaging features for differentiating PDAC from MFP in the training set. Based on the identified predictors, two nomogram models were constructed: the US model and the US + CEUS model. The diagnostic performance of both models was assessed via the area under the receiver operating characteristic curve (AUC), calibration plots, Hosmer-Lemeshow test, and decision-curve analysis (DCA). Results Multivariate logistic regression analysis based on these factors identified taller-than-wide shape (P = 0.002, OR = 0.12), calcification (P = 0.003, OR = 13.76), and washout pattern (P = 0.002, OR = 0.13) as independent predictive factors for distinguishing PDAC from MFP. Compared to the US model, the US + CEUS model demonstrated better performance with AUC values 0.930 (95% CI: 0.895–0.965) in the training set and 0.914 (95% CI: 0.853–0.976) in the validation set. Calibration curve plots and the Hosmer-Lemeshow test (P > 0.05) confirmed that the model has good calibration, and DAC showed significant clinical benefit. Conclusion The nomogram model constructed using taller-than-wide shape, calcification, and washout pattern demonstrated excellent discriminative ability, accuracy, and clinical utility in differentiating PDAC from MFP.


  • Looking at or beyond the tumor - a systematic review and meta-analysis of quantitative imaging biomarkers predicting pancreatic cancer prognosis

    by Zihe Wang, Liang Zhu, Yitan Wang, Xianlin Han, Qiang Xu, Menghua Dai

    Objectives To evaluate the prognostic value of quantitative imaging biomarkers derived from computed tomography (CT) and magnetic resonance imaging (MRI) for pancreatic cancer (PC), with a particular focus on body composition parameters beyond the traditional intrinsic features of the tumor. Methods PubMed, EMBASE, and Cochrane Library databases were searched for articles on quantitative imaging biomarkers obtained from CT or MRI in predicting PC prognosis published between January 2014 and August 2024. The Newcastle-Ottawa scale was used to assess the quality of the included studies. Survival outcomes, such as overall survival (OS) and recurrence-free survival (RFS), were evaluated. The pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using a random-effects model. In case of high heterogeneity, subgroup analyses and sensitivity analyses were performed to identify potential sources of heterogeneity among the studies. Results We performed a meta-analysis of ten imaging biomarkers investigated in 43 included studies. Larger tumor size, lower skeletal muscle radiodensity, lower skeletal muscle index (SMI), presence of sarcopenic obesity, lower psoas muscle index (PMI), higher visceral to subcutaneous adipose tissue area ratio, and lower visceral adipose tissue index were associated with significantly worse OS. In particular, lower SMI and lower PMI had relatively high HRs (1.65 for SMI, 95% CI 1.39–1.96, and 2.20 for PMI, 95% CI 1.74–2.78). Patients with lower SMI exhibited poorer RFS (HR 1.78, 95% CI 1.46–2.18). Subgroup analyses identified the origin region of the study and intervention type as potential factors of heterogeneity for SMI in predicting OS. Conclusions Imaging biomarkers indicating body composition at PC diagnosis may play an important role in predicting patient prognosis. Further prospective multi-center studies with large sample sizes are needed for validation and translation into clinical practice. Graphical Abstract


  • Open Access

    Long-term Outcomes of Surgical Treatment for Pancreatic Neuroendocrine Neoplasm With Synchronous Hepatic Metastasis

    by Qiang Xu, Bohui Yin, Xu Han, Siqian Ren, Jialin Mm Jiang, Fang Li, Karn Wijarnpreecha, Jingqiao Wang, Quan Liao, Menghua Dai, et al.

    Objective: To evaluate surgical impact on the overall survival (OS) of pancreatic neuroendocrine neoplasm (pNEN) with synchronous hepatic metastases (sHMs). Methods: A total of 163 pNEN-sHM patients were recruited from 3 institutions in China, who were categorized into 3 groups: no resection, resection of the primary lesion, and resection of both primary and hepatic lesions (PHR). Cox regression was employed to evaluate surgical impact on the OS. Results: In the overall cohort analysis, PHR demonstrated a significant protective effect on OS (hazard ratio, 0.302; 95% confidence interval, 0.127–0.721; P = 0.007). Nevertheless, subgroup analysis revealed PHR conferred a survival advantage in patients with pancreatic neuroendocrine tumor (pNET) located on the pancreatic body/tail (bt-pNET-sHM) (hazard ratio, 0.287; 95% CI, 0.087–0.946; P = 0.040), whereas surgical treatment did not significantly impact survival in the subgroups of pancreatic neuroendocrine carcinoma–sHM or pancreatic head/neck pNET-sHM (hn-pNET-sHM). Conclusions: In this study, the survival benefit of surgery was observed only in the bt-pNET-sHM subgroup. Considering the multifactorial nature of decision-making, surgical intervention for pNEN-sHM management should be approached with a careful and comprehensive assessment, to prevent excessive surgery strategies.


  • Open Access

    Local resection for solid pseudopapillary neoplasms of the pancreas shows improved postoperative gastrointestinal function and reduced mental stress: a multiquestionnaire survey from a large cohort

    by Yuze Hua, Xia Hong, Menghua Dai, Jiayi Li, Sen Yang, Junchao Guo, Weibin Wang, Qiang Xu, Xianlin Han, Mengyi Wang, et al.

    Background: Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare, low-grade malignant pancreatic tumor with a highly favorable prognosis. Most SPN patients are young and middle-aged women. The main controversial topic for SPN is local resection (LR) versus radical resection (RR). Theoretically, LR could lead to better gastrointestinal function (GIF) and less mental stress. However, no data is available to support this hypothesis. Methods: All SPN patients undergoing surgical treatment in Peking Union Medical College Hospital from 2001 to 2021 were included in the study. A cross-sectional online multiquestionnaire survey containing 110 questions was sent to them (Clinicaltrial.org, NCT05604716). This online multiquestionnaire survey focused on GIF and mental stress and consisted of eight questionnaires. Multiple linear regression analysis was conducted to identify independent factors impacting GIF and mental stress. Results: A total of 183 cases provided valid results. Among them, 46 patients (25.1%) underwent LR, and 137 (74.9%) underwent RR. Ninety-four cases (51.4%) underwent minimally invasive surgery (MIS), while 89 (48.6%) underwent open surgery. The average GSRS score of the patients was 1.9±0.7, indicating that most suffered from mild gastrointestinal dysfunction. The scores of PHQ-9 and GAD-7 in 16 patients (8.7%) and 27 (14.8%) patients, respectively, were beyond 10.0, which indicated clinical depression and anxiety. Additionally, 19 (10.4%) patients reported poor ability to work, and 31(16.9%) patients had significant body image concerns. Compared to other clinicopathological characteristics, LR (LR vs. RR: PHQ-9 score, P=0.018; WAI average score, P=0.010; EORTC QLQ-C30, nine subdomains, PP=0.006) and MIS (MIS vs. open surgery: EORTC QLQ-C30, three subdomains, PP=0.006) were the most significant factors predicting improved GIF and reduced mental stress. Conclusions: This study systematically presents postoperative GIF and mental stress of SPN patients using validated multiquestionnaires for the first time. It provides solid evidence that LR and MIS can improve GIF and reduce mental stress after surgery for SPN patients, which could be helpful for the surgeons to make more personalized surgical plans for their patients.


  • Open Access

    Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ultrasound

    by Wan-Ying Jia, Yang Gui, Xue-Qi Chen, Li Tan, Jing Zhang, Meng-Su Xiao, Xiao-Yan Chang, Xin-Ting Sang, Meng-Hua Dai, Jun-Chao Guo, et al.

    Original Article Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast- enhanced ultrasound Wan-Ying Jia, Yang Gui, Xue-Qi Chen, Li Tan, Jing Zhang, Meng-Su Xiao, Xiao-Yan Chang, Xin-Ting Sang, Meng-Hua Dai, Jun-Chao Guo, Chun-Mei Bai, Yue-Juan Cheng, Jing-Lin Li, Xin Yang, Jian-Chu Li, Yu-Xin Jiang, Ke Lv


  • Open Access

    Development of a Nomogram to Predict Disease-Specific Survival for Patients After Resection of a Non-Metastatic Adenocarcinoma of the Pancreatic Body and Tail

    by Yiping Zou, Hongwei Han, Shiye Ruan, Zhixiang Jian, Liang Jin, Yuanpeng Zhang, Zhihong Chen, Zi Yin, Zuyi Ma, Haosheng Jin, et al.

    Background: Models for predicting patient survival after resection of a non-metastatic adenocarcinoma of the pancreatic body and tail (APBT) are scarce. We wished to establish and validate a nomogram to predict disease-specific survival (DSS) of these patients. Methods: A total of 1,435 patients screened from the Surveillance, Epidemiology, and End Results (SEER) database were included and divided randomly into a training set (TS; n = 1,007) and internal validation set (IVS; n = 428) at a ratio of 7:3. Cox regression analyses were conducted to select independent predictors in the TS, and a nomogram was constructed. The model was subjected to the IVS and an external validation set (EVS) comprising 151 patients from two tertiary hospitals. Results: Five independent risk factors (age at the diagnosis, chemotherapy, tumor grade, T stage, and the lymph node radio) were identified and integrated into the nomogram. Calibration curves indicated that the nomogram could predict DSS at 1, 2, and 3 years accurately. The nomogram had a higher concordance index for predicting DSS compared with that using the 8th edition of the American Joint 23 Committee on Cancer (AJCC8) stage (TS: 0.681 vs. 0.606; IVS: 0.662 vs. 0.590; and EVS: 0.675 vs. 0.608). The nomogram had better discrimination ability and clinical utility than the AJCC8 stage for predicting 1-, 2-, and 3-year DSS. Conclusion: Our developed nomogram could accurately predict DSS in patients after resection of a non-metastatic APBT.


  • Open Access

    Pancreatic schwannoma mimicking pancreatic cystadenoma

    by Shunda Wang, Cheng Xing, Huanwen Wu, Menghua Dai, Yupei Zhao

    Introduction: Schwannomas, also known as neurilemmoma, are benign neoplasms that originating from Schwann cells in peripheral nerve sheaths. The head, neck, and extremities are the most common sites; however, pancreatic schwannomas are rare neoplasms. Accurate preoperative diagnosis of these tumors is very tough because of pancreatic schwannomas usually mimicking other cystic tumors. Here we present a case of pancreatic schwannoma misdiagnosed as pancreatic cystadenoma. Patient concerns: We presented a rare case of a 55-year-old female admitted to our hospital for abdominal distension. The physical examination and results of laboratory testing reveal no abnormalities. Diagnosis: A computed tomography (CT) scan detected a hypodense 2.4 cm × 2.6 cm mass with a clear margin at the neck of the pancreas. Pancreatic cystadenoma was strongly suspected. Interventions: The patient underwent robotic distal pancreatectomy with splenectomy. The gross specimen showed a pale and solid mass with a capsule. Outcomes: Histological examination of the surgical specimen demonstrated a pancreatic schwannoma. Immunohistochemistry results were as follows: S-100 (+), CD117 (−), SMA (−), and Desmin (−). She was discharged on postoperative day 6 and no recurrence of the tumor happened during the 12-month follow-up. Conclusion: Precise preoperative diagnosis of pancreatic schwannomas is very difficult despite the application of multiple imaging modalities. Surgery is the most effective treatment for this rare disease and the final diagnosis usually relies on pathology. Following complete tumor removal, patients with pancreatic schwannomas generally have a good prognosis.


  • AB111. P085. The key factors related to the postoperative survival duration of patients with pancreatic ductal adenocarcinoma

    by Yatong Li, Menghua Dai

    Pancreatic ductal adenocarcinoma (PDAC) is a rarely highly malignant disease, with a poor prognosis and a low survival rate. PDAC with its characteristics of stealth clinical manifestation, rapid disease development and poor prognosis, is hard to be diagnosed at an early stage. Thus, the lethality of PDAC ranks top four in many countries. The 5-year survival rate of the patients with PDAC was only between 2-6%, which is the lowest in all kinds of cancer. Surgery is the main treatment method, but it is hard to stop the progress of the disease completely. As the technology of radical surgery becoming mature, and the adjuvant radiochemotherapy becoming common, the postoperative 5-year survival rate of the patients with PDAC in our hospital was up to about 10%, and the median survival time was up to 30 months. According to our long-term follow-up results, some patients with the same pathological diagnosis did survive much longer than the others after the same radical operation. Therefore, we separated those patients into two groups (postoperative survival duration Lamp2, Tmem219, TTI2, Rdm1, Ppp2ca, Ezr, Serpini2, and Cep85, were detected to have the most important mutations between these 2 groups, as well as Twist1, Ywhaz, Sqstm1, Gna13, Lrig1, and Myc, were proved to have the most significant changes in their expression levels. Experiments in vitro and vivo had confirmed these findings, and the most crucial genes related to the postoperative survival of patients with PDAC emerged.